Instadose US Announces Management Transition – PRNewswire


CHESAPEAKE, Va., Jan. 14, 2022 /PRNewswire/ – The Board of Directors of Instadose Pharma Corp., a Nevada corporation, (“Instadose US”) announced that effective January 14, 2022, they have accepted the planned resignation of Grant F. Sanders as Chairman and CEO of Instadose US and as Chairman of its wholly owned Canadian subsidiary (“Instadose Canada”).  Mr. Sanders will not hold any officer or director positions at Instadose US or Instadose Canada following his resignation.

Mr. Sanders had committed to lead Instadose Canada through its transition to a publicly traded US company (Instadose US), as outlined in the Final Order of the Supreme Court of British Columbia approving the plan of arrangement between Instadose US and Instadose Canada. After completion of the share exchange on December 31, 2021, which was the exchange of shares from Instadose Canada to Instadose US, and the first record setting international Cannabis shipment, Mr. Sanders has paved the road to success for the Instadose US business model.  “I feel confident that the new management team and corporate structure is in excellent position to execute on my vision of Instadose US becoming the largest global distribution platform for medicinal cannabis,” stated Mr. Sanders.

During a 30-day transition period, Mr. Sanders will continue to support Instadose US and its wholly owned subsidiary (Instadose Canada) with his in-depth knowledge of this global cannabis distribution platform. 

Alex Wylie will assume the role of interim Chairman of Instadose US, and interim CEO of Instadose US and Instadose Canada Mr. Wylie will continue in his role as CFO of Instadose US and Instadose Canada.  Instadose US’ Board of Directors will initiate a process to find a permanent Chairman and CEO of Instadose US.  Alex Wylie will be a potential candidate for the role of CEO and/or Chairman.     

Ed Borkowski has decided not to accept the position of CEO of Instadose Canada and instead agreed to assume the

Read More Here...

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top